PDCD1 and lung cancer: When weighting benefit and potential risk of seasonal influenza vaccination for patients undergoing single-agent PD-1 or PD-L1 blockade – in particular those with lung cancer – we currently advice to make an individual decision against or for an influenza vaccination until results from larger cohorts are available.